Toshio Kawanami

Discovery of 4-((2 <i>S</i> ,4 <i>S</i> )-4-Ethoxy-1-((5-methoxy-7-methyl-1 <i>H</i> -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases

Nello Mainolfi, Takeru Ehara, Rajeshri G. Karki et al. · Journal of Medicinal Chemistry · 2020 · 57 citations

Discovery and Characterization of Allosteric WNK Kinase Inhibitors

Ken Yamada, Ji-Hu Zhang, Xiaoling Xie et al. · ACS Chemical Biology · 2016 · 44 citations · Full text

Molecular Docking, Medicinal Chemistry, Drug Target +12

Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models

Ken Yamada, Julian Levell, Taeyong Yoon et al. · Journal of Medicinal Chemistry · 2017 · 37 citations · Full text

Crystal Structure, Hypertension, Kinase Inhibitors +17

Crystal Structure of a Dewar Benzene Derivative Formed from Fluoro(triisopropylsilyl)acetylene

Takeshi Hanamoto, Yukinori Koga, Toshio Kawanami et al. · Angewandte Chemie International Edition · 2004 · 36 citations

Crystal Structure, Derivative (Chemistry), Derivatives +11

Remarkable effect of tris(4-fluorophenyl)phosphine oxide on the stabilization of chiral lanthanum complex catalysts. A new and practical protocol for the highly enantioselective epoxidation of conjugated enonesElectronic supplementary information (ESI) available: HPLC analysis of 2, 1H NMR data for 3 and 4, and crystal data for 5. See http://www.rsc.org/suppdata/ob/b4/b405882h/

Rie Kino, Kazuhiro Daikai, Toshio Kawanami et al. · Organic & Biomolecular Chemistry · 2004 · 34 citations